ANCA antineutrophil cytoplasmic
Selected indexed studies
- KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. (Kidney Int, 2024) [PMID:38388102]
- Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application. (Clin Exp Rheumatol, 2014) [PMID:24854381]
- Atherosclerosis in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. (Kardiol Pol, 2018) [PMID:28980290]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. (2024) pubmed
- Antineutrophil cytoplasmic antibodies (ANCA) testing: detection methods and clinical application. (2014) pubmed
- Atherosclerosis in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis. (2018) pubmed
- What do antineutrophil cytoplasmic antibodies (ANCA) tell us? (2005) pubmed
- Antineutrophil cytoplasmic antibodies. (2006) pubmed
- Aortitis caused by antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a case-based review. (2019) pubmed
- Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis. (2004) pubmed
- Cardiac manifestations in antineutrophil cytoplasmic autoantibody (ANCA) - associated vasculitides. (2016) pubmed
- [Antineutrophil cytoplasmic antibodies (ANCA) in chronic inflammatory intestinal disease]. (2000) pubmed
- Antineutrophil Cytoplasmic Antibodies Testing and Interpretation. (2019) pubmed